Theravance Biopharma Inc

NASDAQ:TBPH   2:11:04 PM EDT
10.49
-0.11 (-1.04%)
Earnings Announcements

Theravance Biopharma Inc Reports Third Quarter 2022 Financial Results

Published: 11/07/2022 22:29 GMT
Theravance Biopharma Inc (TBPH) - Theravance Biopharma, Inc. Reports Third Quarter 2022 Financial Results, Provides Business Update and Extends Tender Offer.
Qtrly Net Sales $18.7 Million Up 35%.
Qtrly Loss per Share From Continuing Operations $0.21.
Q3 Earnings per Share View $-0.18, Revenue View $11.8 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $15.22 Million
Adjusted EPS is expected to be -$0.09

Next Quarter Revenue Guidance is expected to be $14.71 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.